What does CUSIP 14875P107 represent in this 13F holders report?

CUSIP 14875P107 is the security identifier for CATB - CATABASIS PHARMACEUTICALS IN - COM used to aggregate holder disclosures.

How many institutions held CATB - CATABASIS PHARMACEUTICALS IN - COM in Q2 2015?

20 institutional investors reported CATB - CATABASIS PHARMACEUTICALS IN - COM for Q2 2015. Use the holders table for investor-level position and value details.

CATABASIS PHARMACEUTICALS IN - COM (CATB)

CUSIP: 14875P107

Q2 2015 13F Holders as of 30 Jun 2015

Type / Class: Equity / COM
Total 13F shares: 7,741,236
Share change: +7,741,236
Total reported value: $94,134,000
Price per share: $12.21
Number of holders: 20
Value change: +$94,134,000
Number of buys: 20

Quarterly Holders Quick Answers

What is CUSIP 14875P107?
CUSIP 14875P107 identifies CATB - CATABASIS PHARMACEUTICALS IN - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Related Filing Research

Latest 13F filings for newly reported positions.
Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
Latest 10-Q/10-K reports for financial context tied to this issuer.
Recent insider transactions for executive and insider activity.
SEC investors directory and top value investors for manager drilldown.
Back to full security ownership history.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2015

Recent filing periods for CUSIP 14875P107:

Q1 2019 Q4 2018 Q3 2018 Q2 2018 Q1 2018 Q4 2017 Q3 2017 Q2 2017

Institutional Holders of CATABASIS PHARMACEUTICALS IN - COM (CATB) as of Q2 2015

As of 30 Jun 2015, CATABASIS PHARMACEUTICALS IN - COM (CATB) was held by 20 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 7,741,236 shares. The largest 10 holders included Clarus Ventures, LLC, FMR LLC, Camber Capital Management LLC, DEERFIELD MANAGEMENT CO, SPHERA FUNDS MANAGEMENT LTD., WELLINGTON MANAGEMENT GROUP LLP, Rhenman & Partners Asset Management AB, BVF INC/IL, PUTNAM INVESTMENTS LLC, and VANGUARD GROUP INC. This page lists 20 institutional shareholders reporting positions in this security for the Q2 2015 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.